Preventing a Flu Pandemic with Just a Single Dose: A Potential Safeguard Against a Mutating Menace
MedicagoResearchers found that a single dose of a vaccine being developed by Medicago, Inc., a publicly traded biopharmaceutical company, could protect against not only the avian influenza (H5N1) strain it was designed for, but also another H5N1 strain and a strain of a different flu subtype, called H2N2.